Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 126,301 | 131,167 | 102,215 | 68,730 | 130,692 |
| Cost of Goods | 11,013 | 506 | 11,313 | 1,043 | 21,463 |
| Gross Profit | 115,288 | 130,661 | 90,902 | 67,687 | 109,229 |
| Operating Expenses | 65,708 | 65,280 | 69,638 | 84,664 | 63,246 |
| Operating Income | 49,593 | 65,887 | 21,577 | -16,934 | 46,446 |
| Interest Expense | 7,123 | 10,457 | 9,430 | 9,592 | 9,586 |
| Other Income | 5,388 | -34,782 | 136 | 4,680 | -11,902 |
| Pre-tax Income | 47,858 | 20,648 | 12,283 | -21,846 | 24,958 |
| Net Income Continuous | 47,858 | 20,648 | 12,283 | -21,846 | 24,958 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -40,451 |
| Net Income | $10,420 | $20,648 | $12,283 | $-21,846 | $-15,493 |
| EPS Basic Total Ops | 0.31 | 0.13 | 0.08 | -0.38 | -0.10 |
| EPS Basic Continuous Ops | 0.31 | 0.13 | 0.08 | -0.14 | 0.17 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.24 | -0.26 |
| EPS Diluted Total Ops | 0.31 | 0.13 | 0.08 | -0.38 | -0.10 |
| EPS Diluted Continuous Ops | 0.31 | 0.13 | 0.08 | -0.14 | 0.17 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.24 | -0.26 |
| EBITDA(a) | $50,460 | $69,061 | $22,428 | $-16,246 | $47,140 |